You would like to read
- Brinton Pharma gets top award for pioneering an impact on Indian industry - Healthcare
- Brinton Pharmaceuticals launches a consumer brand 'Hohner Health' in India to focus on wellness and personal care category
- Alkem Laboratories Ltd. to launch State of the Art Technology for Diabetic Foot Ulcer Management for the first time in India
- Pamper your skin this winter with Vasu Naturals Premium winter care range
- The 5th edition of Lokmat Most Stylish Awards 2021: A memorable night to celebrate glamour, excellence and remarkable success
Pune (Maharashtra) [India], March 2 (ANI/NewsVoir): Brinton, the Indian Pharmaceutical Multinational, which has been steadily increasing its footprint in the Indian and global healthcare sector, in a strategic move today announced a tie-up with the global foot care brand, Scholl Wellness Company, for the sales and distribution of the latter's products in the Indian market, that include the famed brand, Krack Cream.
"We are extremely proud to collaborate with Scholl to build its heritage brands including Krack Cream. Scholl is the global leader in the foot care industry and we have an interest in the area of dermatology among others. Our endeavour is to build on this legacy through our mammoth distribution network and strong marketing capabilities. This will help to build the brand further and reach the pinnacle of success," said Brinton Chairman and Managing Director Rahulkumar Darda.
Scholl, the No.1 foot care brand in the world has an array of foot care products like Arthritis Pain Reliever, Custom Fit Orthotics, different varieties of insoles, Odor-X, a Probiotic Extract Formula Foots Spray, Wart Remover Freeze Away Max, Ingrown Toenail Pain Reliever and Fungal Nail Revitalizer among others. Krack Cream, however, is the most popular brand commanding 80 per cent market share in India.
Scholl offers complete foot care through innovative products for healthier feet. This partnership would further strengthen our resolve to expand our market in India. Interestingly, the global foot care market is expected to reach USD 4.4 billion by 2026.
"The foot care market continues to offer exciting marketing opportunities. Its market size is expected to grow at 7.9 per cent CAGR for the next few years since there is a growing requirement of foot care products for maintaining better aesthetics and ensuring hygiene. Fluctuating lifestyle and altering fashions are augmenting exposure of feet skin," added Darda.
Global market research, in this backdrop, indicates that the demand for foot cleansing lotions, creams and repair ointments would continue to rise. Then, there is also the increasing incidence of diabetes and bacterial infections which is further fuelling the growth of the foot care industry.
A recognised pharma leader that uses innovative and emerging technologies right from product research to formulation development, Brinton has interests in dermatology, paediatric and gynaecology. The company offers several high-quality products related to skin, children, women's health and wellness.
"Our scientific and technical expertise makes us one of the most trusted brands and we believe in delivering world-class products at affordable cost. Our alliance with Scholl is an extremely important step towards strengthening our foothold in the OTC segment. We will penetrate into the market deeper ensuring the availability of Scholl products to a wide variety of customers," Darda informed.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)
DISCLAIMER
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
